Treatment of Acute Graft-versus-Host Disease in Liver Transplant Recipients

Table 1

GVHD-specific markers prior to initiation of ruxolitinib.

Test name	Result	Normal range
Elafin	>80 ng/mL	4.9–23.8 ng/mL
ST 1: soluble TNF-receptor 1	>9.8 ng/mL	<2.5 ng/mL
Reg 3 alpha: regenerating islet-derived 3-alpha	195.5 ng/mL	<89.0 ng/mL
ST 2: soluble TNF-receptor 2	>100.0 ng/mL	<30 ng/mL